Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01859871 · ClinicalTrials.gov registry record · NA

Evaluation of a Website on Living Kidney Donation for Hispanics

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
123
Enrollment target

NCT01859871: Completed NA study, sponsored by Northwestern University.

NCT01859871 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 123 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01859871, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
123 participants
Enrollment target

Study Summary

The purpose of this study is to increase understanding about living kidney donation (LKD) among Hispanic/Latino patients and public by increasing knowledge and positive attitudes about LKD. Improving Hispanics' understanding about LKD will ensure that Hispanic patients and public are fully informed of the treatment options for End Stage Kidney Disease.

Primary Outcome

Will assess change in knowledge and positive attitudes about risks, benefits, processes, and cultural factors associated with living kidney donation over time, and their associations with participant characteristics (i.e., age, literacy).

Interventions

  • BEHAVIORAL Website Intervention

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2013-05
Est. Completion 2015-09
Phase NA
Northwestern University

1,209 total trials

What the finished NCT01859871 record still lists

NCT01859871 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Website Intervention is the first listed.

NCT01859871 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01859871 about?

NCT01859871 is a clinical study titled "Evaluation of a Website on Living Kidney Donation for Hispanics". The purpose of this study is to increase understanding about living kidney donation (LKD) among Hispanic/Latino patients and public by increasing knowledge and positive attitudes about LKD. Improving Hispanics' understanding about LKD will ensure that Hispanic patients and public are fully informed ...

What is the current status of trial NCT01859871?

This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2013-05. Estimated completion is 2015-09.

What interventions are being tested in trial NCT01859871?

The interventions under investigation include: Website Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01859871?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01859871's enrollment target sits among peer trials

123 762nd of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05285891 · 123 participants · Phase 4

    Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

  • NCT05334368 · 123 participants · Phase 3

    Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

  • NCT06088355 · 123 participants · NA

    Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease

  • NCT06111131 · 123 participants · NA

    Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01859871, the US trial registry maintained by the National Library of Medicine. NCT01859871 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.